Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             109 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Active secretion and enterocytic drug metabolism barriers to drug absorption 1 PII of original article: S0169-409X(96)003304. The article was originally published in Advanced Drug Delivery Reviews 20 (1996) 99–112. 1 Wacher, Vincent J
2001
82-83 1-3 p. 89-102
14 p.
artikel
2 Adenovirus-mediated gene transfer to liver 1 1 The article was originally published in Advanced Drug Delivery Reviews 17 (1995) 303–307. Wilson, James M.
2001
82-83 1-3 p. 205-209
5 p.
artikel
3 Airway delivery of cationic lipid: DNA complexes for cystic fibrosis Cheng, S.H
1998
82-83 1-3 p. 173-184
12 p.
artikel
4 A novel RU486 inducible system for the activation and repression of genes Chua, Steven S
1998
82-83 1-3 p. 23-31
9 p.
artikel
5 Antibodies as delivery systems for diagnostic functions Khaw, Ban-An
1999
82-83 1-3 p. 63-80
18 p.
artikel
6 Antibody delivery through the blood-brain barrier Bickel, Ulrich
1995
82-83 1-3 p. 53-72
20 p.
artikel
7 Antisense drug delivery through the blood-brain barrier Boado, Ruben J.
1995
82-83 1-3 p. 73-107
35 p.
artikel
8 Applications of the Caco-2 model in the design and development of orally active drugs: elucidation of biochemical and physical barriers posed by the intestinal epithelium Gan, Liang-Shang L.
1997
82-83 1-3 p. 77-98
22 p.
artikel
9 Approaches and agents for imaging the vascular system Bogdanov Jr., Alexei A
1999
82-83 1-3 p. 279-293
15 p.
artikel
10 Arterial gene transfer of naked DNA for therapeutic angiogenesis: early clinical results Isner, Jeffrey M
1998
82-83 1-3 p. 185-197
13 p.
artikel
11 Assaying extrachromosomal gene therapy vectors that carry replication/persistence elements Sclimenti, Christopher R
1998
82-83 1-3 p. 13-21
9 p.
artikel
12 Avidin–biotin system for delivery of diagnostic agents Sakahara, Harumi
1999
82-83 1-3 p. 89-101
13 p.
artikel
13 Bacteria-derived particles as adjuvants for non-replicating nasal vaccines Haneberg, Bjørn
2001
82-83 1-3 p. 143-147
5 p.
artikel
14 Biochemical opening of the blood-brain barrier Black, Keith L.
1995
82-83 1-3 p. 37-52
16 p.
artikel
15 Caco-2 monolayers in experimental and theoretical predictions of drug transport 1 PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84. 1 Artursson, Per
2001
82-83 1-3 p. 27-43
17 p.
artikel
16 Chemistry and cellular aspects of cationic facial amphiphiles Walker, Suzanne
1998
82-83 1-3 p. 61-71
11 p.
artikel
17 Chitosan as a novel nasal delivery system for vaccines Illum, L
2001
82-83 1-3 p. 81-96
16 p.
artikel
18 Concepts for the design of anti-HIV nucleoside prodrugs for treating cephalic HIV infection Wiebe, Leonard I.
1999
82-83 1-3 p. 63-80
18 p.
artikel
19 Cystic fibrosis clinical trials Geddes, Duncan
1998
82-83 1-3 p. 205-217
13 p.
artikel
20 Cytokines as adjuvants for the induction of mucosal immunity Boyaka, Prosper N.
2001
82-83 1-3 p. 71-79
9 p.
artikel
21 Delivery of contrast agents for magnetic resonance imaging, computed tomography, nuclear medicine and ultrasound Tilcock, Colin
1999
82-83 1-3 p. 33-51
19 p.
artikel
22 Delivery of contrast agents for positron emission tomography imaging by liposomes Oku, Naoto
1999
82-83 1-3 p. 53-61
9 p.
artikel
23 Delivery of diagnostic agents: achievements and challenges Wolf, Gerald L
1999
82-83 1-3 p. 1-12
12 p.
artikel
24 Delivery of diagnostic agents for gamma-imaging Arano, Yasushi
1999
82-83 1-3 p. 103-120
18 p.
artikel
25 Delivery of diagnostic agents for magnetic resonance imaging Okuhata, Yoshitaka
1999
82-83 1-3 p. 121-137
17 p.
artikel
26 Delivery of diagnostic agents in computed tomography Krause, Werner
1999
82-83 1-3 p. 159-173
15 p.
artikel
27 Delivery of gamma-imaging agents by liposomes Phillips, William T.
1999
82-83 1-3 p. 13-32
20 p.
artikel
28 Delivery of imaging agents into brain Abbott, N.Joan
1999
82-83 1-3 p. 253-277
25 p.
artikel
29 Delivery of molecular and cellular medicine to solid tumors 1 PII of original article: S0169-409X(97)00027-6. The article was originally published in Advanced Drug Delivery Reviews 26 (1997) 71–90. 1 Jain, Rakesh K
2001
82-83 1-3 p. 149-168
20 p.
artikel
30 Delivery of peptides and proteins through the blood–brain barrier Bickel, Ulrich
2001
82-83 1-3 p. 247-279
33 p.
artikel
31 Delivery of radioligands for positron emission tomography (PET) in the central nervous system Tsukada, Hideo
1999
82-83 1-3 p. 175-188
14 p.
artikel
32 Delivery systems for penetration enhancement of peptide and protein drugs: design considerations Kompella, Udaya Bhaskar
2001
82-83 1-3 p. 211-245
35 p.
artikel
33 Development and optimization of anti-HIV nucleoside analogs and prodrugs: Tan, Xiaolei
1999
82-83 1-3 p. 117-151
35 p.
artikel
34 Discrimination between drug candidates using models for evaluation of intestinal absorption Stewart, Barbra H.
1997
82-83 1-3 p. 27-45
19 p.
artikel
35 Editorial 2001
82-83 1-3 p. 1-2
2 p.
artikel
36 Editorial Board 1995
82-83 1-3 p. ii-iii
nvt p.
artikel
37 Editorial Board 1997
82-83 1-3 p. ii-
1 p.
artikel
38 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Lipinski, Christopher A.
1997
82-83 1-3 p. 3-25
23 p.
artikel
39 Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1 PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1 Lipinski, Christopher A
2001
82-83 1-3 p. 3-26
24 p.
artikel
40 Factors affecting short-term and long-term stabilities of proteins Arakawa, Tsutomu
2001
82-83 1-3 p. 307-326
20 p.
artikel
41 Forthcoming events 1995
82-83 1-3 p. 179-180
2 p.
artikel
42 Forthcoming issues 1995
82-83 1-3 p. 177-
1 p.
artikel
43 Gene delivery systems: Bridging the gap between recombinant viruses and artificial vectors Lehn, Pierre
1998
82-83 1-3 p. 5-11
7 p.
artikel
44 Genetically engineered antibodies and their application to brain delivery Morrison, Sherie L.
1995
82-83 1-3 p. 147-175
29 p.
artikel
45 Gene transfer with lipospermines and polyethylenimines Remy, Jean-Serge
1998
82-83 1-3 p. 85-95
11 p.
artikel
46 Immobilized Artificial Membranes — screens for drug membrane interactions Yang, Cheng Y.
1997
82-83 1-3 p. 229-256
28 p.
artikel
47 Immobilized liposome chromatography of drugs for model analysis of drug-membrane interactions Lundahl, Per
1997
82-83 1-3 p. 221-227
7 p.
artikel
48 Immunostimulating complexes (ISCOMs) for nasal vaccination Hu, Ke-Fei
2001
82-83 1-3 p. 149-159
11 p.
artikel
49 Improved uptake and retention of lipophilic prodrug to improve treatment of HIV Yatvin, Milton B
1999
82-83 1-3 p. 165-182
18 p.
artikel
50 Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract 1 PII of original article: S0169-409X(96)00487-5. The article was originally published in Advanced Drug Delivery Reviews 25 (1997) 3–14. 1 Hörter, D
2001
82-83 1-3 p. 75-87
13 p.
artikel
51 Interpolyelectrolyte and block ionomer complexes for gene delivery: physico-chemical aspects Kabanov, Alexander V
1998
82-83 1-3 p. 49-60
12 p.
artikel
52 Intranasal vaccination against plague, tetanus and diphtheria Alpar, H.O
2001
82-83 1-3 p. 173-201
29 p.
artikel
53 Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system Sawchuk, Ronald J.
1999
82-83 1-3 p. 5-31
27 p.
artikel
54 In vitro models for selection of development candidates. Permeability studies to define mechanisms of absorption enhancement LeCluyse, Edward L.
1997
82-83 1-3 p. 163-183
21 p.
artikel
55 In vitro models to predict blood-brain barrier permeability Eddy, Evangeline Priya
1997
82-83 1-3 p. 185-198
14 p.
artikel
56 In vitro permeability of peptidomimetic drugs: The role of polarized efflux pathways as additional barriers to absorption Burton, Philip S.
1997
82-83 1-3 p. 143-156
14 p.
artikel
57 In vitro permeability screening for identification of orally bioavailable endothelin receptor antagonists Ellens, Harma
1997
82-83 1-3 p. 99-109
11 p.
artikel
58 Involvement of multiple transporters in the oral absorption of nucleoside analogues Balimane, Praveen V.
1999
82-83 1-3 p. 183-209
27 p.
artikel
59 Key issues in non-viral gene delivery 1 PII of original article: S0169-409X(98)00048-9. The article was originally published in Advanced Drug Delivery Reviews 34 (1998) 3–19. 1 Pouton, Colin W
2001
82-83 1-3 p. 187-203
17 p.
artikel
60 Liposomes for scintigraphic detection of infection and inflammation Laverman, Peter
1999
82-83 1-3 p. 225-235
11 p.
artikel
61 Manipulating the immune system: humoral versus cell-mediated immunity McNeela, Edel A.
2001
82-83 1-3 p. 43-54
12 p.
artikel
62 Manufacturing and quality control of plasmid-based gene expression systems Durland, Ross H
1998
82-83 1-3 p. 33-48
16 p.
artikel
63 Mechanisms of transport of nucleosides and nucleoside analogues in choroid plexus Schaner, Marci E
1999
82-83 1-3 p. 51-62
12 p.
artikel
64 Microparticles for intranasal immunization Vajdy, Michael
2001
82-83 1-3 p. 127-141
15 p.
artikel
65 Multiple-model evaluation of absorption of a tachykinin receptor antagonist Chan, O.Helen
1997
82-83 1-3 p. 121-131
11 p.
artikel
66 Nasal delivery of epitope based vaccines Olszewska, Wieslawa
2001
82-83 1-3 p. 161-171
11 p.
artikel
67 Nasal vaccination: a non-invasive vaccine delivery method that holds great promise for the future 2001
82-83 1-3 p. 1-3
3 p.
artikel
68 Nasal vaccination using live bacterial vectors Mielcarek, Nathalie
2001
82-83 1-3 p. 55-69
15 p.
artikel
69 Nasal vaccines Davis, S.S.
2001
82-83 1-3 p. 21-42
22 p.
artikel
70 Non-antibiotic anti-diarrhoeal drugs: factors affecting oral bioavailability of berberine and loperamide in intestinal tissue Baird, Alan W.
1997
82-83 1-3 p. 111-120
10 p.
artikel
71 Oral absorption of β-lactams by intestinal peptide transport proteins Dantzig, Anne H.
1997
82-83 1-3 p. 63-76
14 p.
artikel
72 Oral absorption of the HIV protease inhibitors: a current update Williams, Gregory C.
1999
82-83 1-3 p. 211-238
28 p.
artikel
73 P-glycoprotein, secretory transport, and other barriers to the oral delivery of anti-HIV drugs Aungst, Bruce J.
1999
82-83 1-3 p. 105-116
12 p.
artikel
74 Pharmacokinetic considerations in somatic gene therapy Ledley, Fred D
1998
82-83 1-3 p. 133-150
18 p.
artikel
75 Plasmid delivery to muscle: Mumper, Russell J
1998
82-83 1-3 p. 151-172
22 p.
artikel
76 Polylysine-based transfection systems utilizing receptor-mediated delivery Zauner, Wolfgang
1998
82-83 1-3 p. 97-113
17 p.
artikel
77 Polymeric lamellar substrate particles for intranasal vaccination Jabbal-Gill, Inderjit
2001
82-83 1-3 p. 97-111
15 p.
artikel
78 Polymeric micelles as carriers of diagnostic agents Trubetskoy, Vladimir S.
1999
82-83 1-3 p. 81-88
8 p.
artikel
79 Preclinical and clinical study of HER-2/neu-targeting cancer gene therapy Hung, Mien-Chie
1998
82-83 1-3 p. 219-227
9 p.
artikel
80 Pre-clinical trials using hepatic gene delivery Grove, Robert I
1998
82-83 1-3 p. 199-204
6 p.
artikel
81 Preface Rolland, Alain
1998
82-83 1-3 p. 1-3
3 p.
artikel
82 Preface Lee, Yong Hee
1999
82-83 1-3 p. 1-3
3 p.
artikel
83 Preface Smith, Philip
1997
82-83 1-3 p. 1-
1 p.
artikel
84 Preface: Overview of brain drug delivery Pardridge, William M.
1995
82-83 1-3 p. 1-3
3 p.
artikel
85 Radionuclide imaging of cardiac pathology: a mechanistic perspective Bhatnagar, Anish
1999
82-83 1-3 p. 213-223
11 p.
artikel
86 Recent advances in liposome technologies and their applications for systemic gene delivery Chonn, Arcadio
1998
82-83 1-3 p. 73-83
11 p.
artikel
87 Responsive polymeric delivery systems Kost, Joseph
2001
82-83 1-3 p. 125-148
24 p.
artikel
88 Review of intranasal influenza vaccine Glueck, Reinhard
2001
82-83 1-3 p. 203-211
9 p.
artikel
89 Role of dosage regimen in controlling indirect pharmacodynamic responses 1 PII of the original article: S0169-409X(98)—30-1. The article was originally published in Advanced Drug Delivery Reviews 33 (1998) 221–233. 1 Gobburu, Jogarao V.S.
2001
82-83 1-3 p. 45-57
13 p.
artikel
90 Role of pharmacokinetics in the discovery and development of indinavir Lin, Jiunn H.
1999
82-83 1-3 p. 33-49
17 p.
artikel
91 Selection of development candidates based on in vitro permeability measurements Lee, Chao-Pin
1997
82-83 1-3 p. 47-62
16 p.
artikel
92 Simulation models to predict oral drug absorption from in vitro data Grass, George M.
1997
82-83 1-3 p. 199-219
21 p.
artikel
93 SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy Maeda, Hiroshi
2001
82-83 1-3 p. 169-185
17 p.
artikel
94 Studies of macromolecular prodrugs of zidovudine Giammona, G.
1999
82-83 1-3 p. 153-164
12 p.
artikel
95 Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography Moghimi, S.M.
1999
82-83 1-3 p. 295-312
18 p.
artikel
96 Synthetic biomimetic supra molecular Biovector™ (SMBV™) particles for nasal vaccine delivery von Hoegen, Paul
2001
82-83 1-3 p. 113-125
13 p.
artikel
97 Synthetic peptide-based DNA complexes for nonviral gene delivery Smith, Louis C
1998
82-83 1-3 p. 115-131
17 p.
artikel
98 Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging Klibanov, Alexander L.
1999
82-83 1-3 p. 139-157
19 p.
artikel
99 Targeted imaging of infection Babich, John W.
1999
82-83 1-3 p. 237-252
16 p.
artikel
100 The effect of chemical modifications on octanol/water partition (log D) and permeabilities across Caco-2 monolayers Rubas, Werner
1997
82-83 1-3 p. 157-162
6 p.
artikel
101 The nose and paranasal sinuses physiology and anatomy Jones, Nick
2001
82-83 1-3 p. 5-19
15 p.
artikel
102 The potential use of receptor-mediated endocytosis for oral drug delivery 1 PII of original article: S0169_409X(96)00334-1. The article was originally published in Advanced Drug Delivery Reviews 20 (1996) 83–97. 1 Russell-Jones, G.J
2001
82-83 1-3 p. 59-73
15 p.
artikel
103 The role of electroosmotic flow in transdermal iontophoresis Pikal, Michael J.
2001
82-83 1-3 p. 281-305
25 p.
artikel
104 The role of γ-scintigraphy in oral drug delivery Wilding, I.R
2001
82-83 1-3 p. 103-124
22 p.
artikel
105 The use of rabbit intestinal permeability as an in vitro assay in the search for orally active GPIIb/IIIa antagonists Samanen, James M.
1997
82-83 1-3 p. 133-142
10 p.
artikel
106 Transport, metabolism and elimination mechanisms of anti-HIV agents Li, Xiaoling
1999
82-83 1-3 p. 81-103
23 p.
artikel
107 Transport of small molecules through the blood-brain barrier: biology and methodology Pardridge, William M.
1995
82-83 1-3 p. 5-36
32 p.
artikel
108 Utilization of metabolic, transport and receptor-mediated processes to deliver agents for cancer diagnosis Cutler, Cathy S.
1999
82-83 1-3 p. 189-211
23 p.
artikel
109 Vector-mediated peptide drug delivery to the brain Pardridge, William M.
1995
82-83 1-3 p. 109-146
38 p.
artikel
                             109 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland